Sonnet BioTherapeutics Stock Guidance | NASDAQ:SONN | Benzinga

Sonnet BioTherapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Sonnet BioTherapeutics Holdings Inc (SONN) does not provide guidance data

FAQ

Q

What is the most recent guidance for Sonnet BioTherapeutics (SONN)?

A

There have been no specific sales or earnings guidance reported for Sonnet BioTherapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch